Skip to main content

Peer Review reports

From: Efficacy of 104-week Telbivudine-based optimization strategy in patients with HBeAg-negative chronic hepatitis B virus infections

Original Submission
23 Aug 2020 Submitted Original manuscript
31 Aug 2020 Author responded Author comments - Wei-qiang Gan
Resubmission - Version 2
31 Aug 2020 Submitted Manuscript version 2
7 Sep 2020 Author responded Author comments - Wei-qiang Gan
Resubmission - Version 3
7 Sep 2020 Submitted Manuscript version 3
28 Sep 2020 Reviewed Reviewer Report
7 Oct 2020 Reviewed Reviewer Report
26 Oct 2020 Author responded Author comments - Wei-qiang Gan
Resubmission - Version 4
26 Oct 2020 Submitted Manuscript version 4
28 Oct 2020 Author responded Author comments - Wei-qiang Gan
Resubmission - Version 5
28 Oct 2020 Submitted Manuscript version 5
30 Oct 2020 Author responded Author comments - Wei-qiang Gan
Resubmission - Version 6
30 Oct 2020 Submitted Manuscript version 6
Publishing
19 Nov 2020 Editorially accepted
7 Dec 2020 Article published 10.1186/s12879-020-05642-y

You can find further information about peer review here.

Back to article page